Under German law (HWG) this content may only be accessed by members of the medical and pharmaceutical professions.
Please log in using your DocCheck password. »

Dr. Falk Video-Report – PART 4 of the Satellite Symposium „EoE – State of the Art“, which took place during the ueg week 2018 in Vienna (Austria). Prof. Dr. Stephan Mielke, Hannover (Germany) talked about “Therapeutic strategies” in Eosinophilic Esophagitis.
©2019 Dr. Falk Pharma GmbH, Freiburg. All rights reserved.


EoE – State of the Art – PART 4: Therapeutic strategies in EoE


The most important facts summarized:

  • Topical corticosteroids are efficient in inducing a clinico-histological remission in EoE patients
  • Topical corticosteroids are more efficient in maintaining clinico-histological remission in EoE patients than placebo
  • Topical corticosteroids significantly reduce the risk of a bolus impaction in EoE patients compared to placebo
  • Withdrawal of topical corticosteroids in patients with deep remission is leading to a relapse in around 80% of the cases
  • Most EoE patients need a long term treatment for their disease, for example with topical corticosteroids

 

More Videos

02:51
EoE – State of the Art – PART 3

03:15
EoE – State of the Art – PART 2

02:45
EoE – State of the Art – PART 1

04:24
Enquired... Prof. Dr. Alex Staumann

04:19
Diagnostic gastroscopy - Eosinophilic esophagitis

Related Charts

Eosinophilic Esophagitis - Some clinical relevant facts